GP-Act III Acquisition Corp. has taken significant steps to secure its future by entering into Non-Redemption Agreements with shareholders. This move comes ahead of an important vote regarding its proposed merger with Dronamics Group Limited. The agreements aim to prevent the redemption of shares, which could jeopardize the merger and the company’s financial stability.

The agreements involve shareholders agreeing not to redeem a total of 2,525,000 Class A ordinary shares during the upcoming extraordinary general meeting scheduled for November 12, 2026. This meeting will address the Extension Amendment Proposal and the Trust Amendment Proposal, both critical for the company's operations.

Background

GP-Act III Acquisition Corp. operates under the SIC classification of Blank Checks (6770) and is listed on the Nasdaq under the tickers GPAT, GPATU, and GPATW. The company was previously known as GP Investments Acquisition Corp. II before its name change in December 2020. Its business address is located at 300 Park Avenue, 2nd Floor, New York, NY.

What the Filing Says

According to the recent SEC filing (accession number 0001213900-26-118277), the Non-Redemption Agreements stipulate that shareholders will not redeem their shares in exchange for receiving a portion of existing Class A ordinary shares held by the company’s sponsor. This arrangement is expected to enhance the likelihood of approval for the proposals at the upcoming meeting.

Impact

This development is crucial for both the company and its shareholders. If the proposals are approved, it will allow GP-Act III Acquisition Corp. to extend the deadline for completing its business combination with Dronamics from November 13, 2026, to May 8, 2027. The agreements are designed to ensure that sufficient funds remain in the company’s trust account, which is vital for the merger's success.

What's Next

The extraordinary general meeting will take place on November 12, 2026, where shareholders will vote on the Extension Amendment Proposal and the Trust Amendment Proposal. The outcome of this meeting will determine the future direction of GP-Act III Acquisition Corp. and its merger plans.